Multiple Sclerosis

WEST PALM BEACH, Fla. — Two experts debated the issue of whether subtypes of multiple sclerosis exist, one from Europe and the other from the United States, during the final day of ACTRIMS.

WEST PALM BEACH, Fla. — Revisions made in 2024 to the McDonald criteria allowed for the diagnosis of multiple sclerosis in a small cohort of individuals with atypical presentation, according to a speaker at ACTRIMS.

WEST PALM BEACH, Fla. — Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, findings confirmed by data from a series of new imaging techniques and presented at ACTRIMS.

WEST PALM BEACH, Fla. — Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who had a greater number of MRI paramagnetic rim lesions at baseline, data show.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is associated with a risk for anaphylaxis and issued a new boxed warning, according to a drug safety communication.

WASHINGTON — Herpes zoster vaccination is effective in patients with systemic lupus erythematosus and multiple sclerosis, without increasing the risk for severe lupus flares, according to data presented at ACR Convergence 2024.

The corneal nerve parameters of patients with multiple sclerosis could be used to evaluate and monitor the stages of the disease, according to a poster presented at the Women in Ophthalmology Summer Symposium.

Genentech announced it received FDA approval for Ocrevus Zunovo to treat patients with relapsing and primary progressive multiple sclerosis, according to a company press release.

From 2022 to 2023, U.S. birth and fertility rates dropped while the percentage of women receiving no prenatal care rose, according to a report from the CDC.